Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments (PCS-HBOT Study)

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Over 500 million people have been infected with COVID-19, and to date, more than 6 million people have died. Many individuals who have recovered from COVID-19 continue to experience symptoms even after they have been cured of the disease. This condition is known as post COVID-19 condition, which can have serious health consequences. A common symptom among these individuals is chronic fatigue, characterized by persistent tiredness or lack of energy. This study aims to explore a novel treatment for symptoms of post COVID-19 condition, known as hyperbaric oxygen therapy. This approach has shown promise in helping people with post COVID-19 conditions and treating some other causes of fatigue. Hyperbaric oxygen therapy involves placing patients in a small chamber where they receive high oxygen gas levels. However, this treatment is expensive and time-consuming, and it is unclear if this treatment can be effectively assessed in a large-scale research study. This small study will help us decide if conducting a large research study is feasible. The investigators aim to assess if hyperbaric oxygen therapy can improve symptoms of post COVID-19 condition, such as fatigue.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥ 18 years old

• Officially diagnosed with post COVID-19 condition by a healthcare practitioner

• At least three months since SARS-CoV-2 infection

• Symptoms that persist more than 12 weeks:

‣ Chronic fatigue (must include) along with one of the following symptoms:

⁃ Difficulty thinking or problem solving ('brain fog')

⁃ Stress or anxiety

Locations
Other Locations
Canada
Sunnybrook Health Sciences Centre
RECRUITING
Toronto
Contact Information
Primary
Fahad Alam, MD
fahad.alam@sunnybrook.ca
416-480-4864
Backup
Lilia Kaustov, PhD
lilia.kaustov@sunnybrook.ca
416 480-6100
Time Frame
Start Date: 2024-01-02
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 40
Treatments
Experimental: Immediate start of hyperbaric treatments
HBOT treatments will be scheduled to start immediately after referral.
Experimental: Delayed start of hyperbaric treatments
HBOT treatments will be scheduled to start 60 days after referral.
Sponsors
Leads: Sunnybrook Health Sciences Centre

This content was sourced from clinicaltrials.gov